Join Thermo Fisher Scientific as we host a Cell and Gene Therapy Virtual Event on
Technology and process advancements in cell and gene therapy development! 
 

With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness this potential, stakeholders across the CGT ecosystems must collaborate to overcome barriers to delivering life-changing treatment to patients. 

Delivered through an interactive virtual platform, this event features over three hours of insightful sessions led by 6 speakers. The discussions will provide industry perspectives on essential success factors for developing CGTs, covering topics such as:

• Large scale processing of mesenchymal stem cells (MSC) and T cell immunotherapies
• Integrated, cutting-edge solutions and process advancements that supports end-to-end workflow 
• Regulatory considerations in raw material selection from research through commericalization 
• Analytical platforms to evaluate the quality, safety, and efficacy of cell-based products

Don't missed the opportunity to engage in a special panel discussion as industry experts discuss the present and future direction of the cell and gene therapy sector through an Asian lens. We will cover topics on:

• The industry outlook, bioanalytical landscape, and updates in cell therapy regulation
• The importance of partnerships within the CGT ecosystem
• Deciding on a commercially viable manufacturing model

Register today!